Literature DB >> 6474417

Inflammatory mediators stimulate granulocyte adherence to cultured human endothelial cells.

G A Zimmerman, H R Hill.   

Abstract

The factors that regulate the adherence of granulocytes to the endothelium under normal conditions, and in states of inflammatory vascular injury, are largely unknown. We found that treatment of primary, confluent monolayers of human umbilical vein endothelial cells with inflammatory mediators (zymosan-activated plasma, as a source of C5a fragments, and N-formylmethionyl-leucyl-phenylalanine) stimulated granulocyte adherence to the monolayers. The augmented adherence was dose-, time-, and temperature-related and demonstrated kinetics characteristic of the adherence of single cells with increased affinity for monolayer cultures. Adherence stimulated by the inflammatory mediators was not prevented by washing the monolayers after treatment with the mediator. Human albumin diminished both spontaneous and stimulated adherence, although the relative increase in adherence stimulated by the inflammatory mediator was unchanged. Calcium and magnesium were required for stimulated adherence. These data suggest that inflammatory mediators may bind to, or directly alter, human endothelial cells resulting in enhanced granulocyte adherence, and define characteristics of this endothelial cell-granulocyte interaction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6474417     DOI: 10.1016/0049-3848(84)90215-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules.

Authors:  M A Perry; D N Granger
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia.

Authors:  R W Colman; D N Flores; R A De La Cadena; C F Scott; L Cousens; P J Barr; I B Hoffman; F Kueppers; D Fisher; S Idell
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion.

Authors:  P I Jara; M P Boric; J C Sáez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

4.  The role of interleukin-1 in neutrophil leukocyte emigration induced by endotoxin.

Authors:  M I Cybulsky; I G Colditz; H Z Movat
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

5.  Neutropenic responses to intradermal injections of Escherichia coli. Effects on the kinetics of polymorphonuclear leukocyte emigration.

Authors:  M I Cybulsky; I J Cybulsky; H Z Movat
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

7.  Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.

Authors:  R Moser; B Schleiffenbaum; P Groscurth; J Fehr
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  C5a-induced expression of P-selectin in endothelial cells.

Authors:  K E Foreman; A A Vaporciyan; B K Bonish; M L Jones; K J Johnson; M M Glovsky; S M Eddy; P A Ward
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro.

Authors:  G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  J Med Case Rep       Date:  2018-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.